RT Book, Section
A1 Schenker, Matthew P.
A1 Baum, Richard A.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Colson, Yolonda L.
A2 Jaklitsch, Michael T.
A2 Krasna, Mark J.
A2 Mentzer, Steven J.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1105845872
T1 Percutaneous Therapy for Traumatic Chylothorax
T2 Adult Chest Surgery, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-178189-3
LK accesssurgery.mhmedical.com/content.aspx?aid=1105845872
RD 2024/10/09
AB Iatrogenic  disruption  of  the  thoracic  duct  is  an  uncommon  but  potentially  serious  complication  of  thoracic  surgery,  particularly  esophagectomy.1  The  thoracic  duct  conveys  chyle  and  lymph  from  the  liver,  intestines,  abdominal  wall,  and  lower  extremities  into  the  systemic  venous  circulation,  and  depending  on  diet  and  activity,  the  flow  of  chyle  through  the  thoracic  duct  can  reach  several  liters  per  day.2  Among  other  components,  this  fluid  contains  essential  proteins,  lipids,  and  lymphocytes.  The  clinical  sequelae  of  unremitting  chylous  effusions  can  be  severe  and  life-threatening,  including  immunosuppression,  respiratory  compromise,  dehydration,  cachexia,  and  death.